SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (546)8/16/2001 1:58:01 AM
From: scaram(o)uche  Read Replies (1) of 656
 
>> Is that close? <<

(answering with a embarrassed blush)

I haven't a clue. Today was the first time that I've read such, as well.

I always assumed that the Enbrel ass'd infectious complications would be shared by Remicade, that the "toxicity" was associated with removing TNF with unfortunate timing. If it *holds* that there is a difference, then...... yeah, that sounds plausible to me. More than plausible, it sounds logical.

I'm not going to run out and try to find supporting studies. If you ever run across an abstract, please post it. Thanks!!

(IR at IMNX would steer us to the relevant studies, if indeed they've been done)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News